Skip to main content
Read Article
Read Article
Read Article
Read Article
Read Article
Read Article
Test
Elevated People Intelligence
You're being asked to manage surging costs, expanding regulations, and increasingly complex employee health needs. The truth is, no off-the-shelf solution can solve that for you. The only thing that can - is elevated people intelligence.
Actionable Data Insights
Turn overwhelming information into intelligence to find a new perspective - like pinpointing the root cause of a chronic condition or better understanding what motivates your people.
Specialized Expertise
Access subject and industry experts to decode your most complex challenges like soaring drug costs, how to improve employee experiences, or understanding the impact of changes to state and local law.
Tailored Outcomes
We listen first, operate transparently, and — because we don’t pre-determine the solution you should buy — we have the ability to right-size the strategy you actually need. Your goals define the recommendation.
Elevated People Intelligence
A few areas where Elevated People Intelligence comes to life.
Workforce Experiences
We support workforce experiences through effective communication strategies, flexible HR outsourcing and insourcing models, and strategic HR consulting aligned to business goals.
Benefits & Total Rewards
Our benefits and total rewards expertise includes health and welfare benefits, compensation and reward design, and absence and leave programs that support employees and employers.
Member Health
We improve member health through population health strategies, pharmacy consulting, and benefit placement that balances access, outcomes, and cost.
Compliance
Our compliance support covers ERISA compliance, HR compliance, and M&A due diligence to help organizations manage regulatory complexity with confidence.
Lorem Ipsum
Lorem ipsum
Lockton's Data Suite
Lockton’s data suite turns information into intelligence. Lockton’s leading data intelligence platform helps answer the business questions. A unique combination of predictive tools, expert analysis, and bold independence allows us to innovate solutions that help you decide confidently.
Learn more about Lockton's Data Suite (opens a new window)
Hear from our industry specialists
More from Lockton specialists
Latest News & Insights
Get the latest news and insights from People Solutions
1 / 6
— Alert
Upcoming key compliance deadlines and reminders for fourth quarter 2026
As we enter the fourth quarter of 2026, employers sponsoring health and welfare benefit plans should turn their attention to several important year-end compliance obligations and planning opportunities. The final months of the year often serve as a c …
— Articles
What's driving healthcare costs, and where should employers focus? Q3 2026 People Solution …
Health plan costs continue to increase at high levels Healthcare costs remain elevated, and employers should prepare for this higher-cost environment to continue. With medical and pharmacy spending putting ongoing pressure on health plans, organizati …
— Alert
Wellness program FAQs: Agencies ease enforcement while courts continue shaping the rules
Last week, the Departments of Labor, Health & Human Services, and Treasury (the Agencies) announced a new non-enforcement position on “full-rewards” offered by health-contingent wellness programs, specifically addressing programs that do not offer a …
— Articles
FTC settlement with CVS Caremark: What employers need to know
The Federal Trade Commission’s (FTC) recent settlement with Caremark Rx LLC and Zinc Health Services LLC (collectively Caremark) marks another significant regulatory intervention in the pharmacy benefit manager (PBM) space. The FTC’s lawsuit focused …
— Alert
DOL proposes updated e-disclosure rule for ERISA group health plans
On July 23, 2026, the DOL’s Employee Benefits Security Administration (EBSA) published a proposed rule on Electronic Disclosure by Group Health Plans Under ERISA, which seeks to create a new, additional safe harbor for group health plan administrator …
— Articles
Cell & gene therapy: Preparing for the next phase of employer health plan risk
Cell and gene therapies are often viewed as an emerging wave of multimillion-dollar costs for employer health plans. While these therapies can exceed $2 million-$4 million per treatment, current employer exposure remains limited because utilization h …